Mayo Clinic Laboratory and Pathology Research Roundup: November 14

By Sarah Jarvis • November 14, 2023

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Personal Actions to Create a Culture of Inclusion: Navigating Difficult Conversations With Medical Colleagues.

Microaggressions between members of a team occur often in medicine, even despite good intentions. Such situations call for difficult conversations that restore inclusivity, diversity, and a healthy work culture. These conversations are often hard because of the unique background, experiences, and biases of each person. In medicine, skillful navigation of these interactions is paramount as it influences patient care and the workplace culture.

Read more.

Published to PubMed This Week

• Ocular Whipple Disease: Cases diagnosed over four decades.
  Ocular Immunology and Inflammation
• Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms.
  Haematologica
• Mayo Clinic consensus report on membranous nephropathy: Proposal for a novel classification.
  Mayo Clinic Proceedings
• Do patients want to be involved in their carpal tunnel surgery decisions? A multicenter study.
  The Journal of Hand Surgery
• Oncolytic alphaherpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses.
  Molecular Therapy
• Adrenal gland solitary fibrous tumor.
  Mayo Clinic Proceedings
• Primary and secondary diagnoses in medicine: Insights from Mayo Clinic consensus report on membranous nephropathy--executive summary.
  Mayo Clinic Proceedings
• Bile duct tumor as the presenting manifestation of colon cancer: A case report.
  Cureus
• Now you see me: Acute and recurrent severe abdominal pain associated with bowel edema.
  Gastroenterology
• Vascular risk, gait, behavioral, and plasma indicators of VCID.
  Alzheimers & Dementia
• Membranous nephropathy treatment standard.
  Nephrology, Dialysis, Transplantation
• Cardiac injury after acute ischemic stroke: Are women at increased risk?
  Journal of the American Heart Association
• Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis.
  Brain: A Journal of Neurology

Sarah Jarvis

Sarah Jarvis is a Senior Marketing Specialist at Mayo Clinic Laboratories. She supports marketing strategies for paid media.